Doxazosin remains a commonly used antihypertensive medication, although its use has been tainted by recent findings from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial ...

You've probably heard or read about congestive heart failure. Maybe you've even been told you have it, or know someone who has. In the future, however, you may not encounter the "congestive" part of ...

Approximately 6.7 million Americans over the age of 20 currently live with heart failure, with this number projected to rise to 8.5 million by 2030. The lifetime risk of developing heart failure has ...

Psychosocial issues are important variables that need to be addressed in patients with congestive heart failure (CHF). Unfortunately, these issues are often overlooked. Depression and lack of social ...

Ischemic CS is characterized by a sudden, massive failure of the heart, most often after an acute myocardial infarction (AMI) or heart attack. Non-ischemic CS is typically triggered by genetics, ...

Kerendia will become available to English patients with chronic heart failure with preserved or mildly reduced ejection ...

Thousands of people in England and Wales with a type of chronic heart failure (CHF) could soon be eligible for treatment with ...

As clinicians, we need to remind ourselves that congestive heart failure (CHF) is not a diagnosis but rather a complex of symptoms with one or more of five major causes: myocardial ischemia, valvular ...

Cardiomyopathy weakens, enlarges, or stiffens the heart muscle. Heart failure is when the heart is unable to pump enough blood around the body, resulting in symptoms. Cardiomyopathy is one of the ...